Oswald Clark, U. S. Correspondent: According to a file submitted by the Food and Drug Administration in federal court, the FDA will not complete its safety study of the abortion pill mifepristone until December and publish its findings until March 2027. American pro-lifers have been pushing the Trump administration to review the Risk Evaluation and Mitigation Strategies (REMS) review of the abortion pill [...]

You are unauthorized to view this entire article. Please log in to your account to receive full access to The Interim.